DEVA HOLDİNG A.Ş. Logo

DEVA HOLDİNG A.Ş.

Global manufacturer of human/veterinary pharmaceuticals, APIs, and medical ampoules.

DEVA

Overview

Corporate Details

ISIN(s):
TRADEVAW91E2
LEI:
959800K5PD9GB1EHW234
Country:
Spain
Address:
AVDA CANTABRIA S / N, 28660 Boadilla del Monte
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1958, DEVA Holding A.Ş. is a prominent pharmaceutical manufacturer. The company's core business activities include the development, production, and marketing of a diverse portfolio of healthcare products. Its primary product lines consist of pharmaceuticals for human use, active pharmaceutical ingredients (APIs), veterinary medicines, and medical ampoules. DEVA Holding operates internationally, utilizing various business models such as distributorships, out-licensing, and supply agreements to market its products globally.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-22 09:48
Board/Management Information
Company General Info Form
English 12.7 KB
2025-10-20 16:53
Board/Management Information
Yönetim Kurulu Üyesi belirlenmesi
Turkish 17.9 KB
2025-10-07 15:46
Board/Management Information
Bağımsız Yönetim Kurulu Üyesinin vefatı hakkında
Turkish 17.2 KB
2025-09-26 15:46
Capital/Financing Update
İpotek fekki
Turkish 17.3 KB
2025-08-22 09:39
Regulatory News Service
Yatırım teşvik belgesi kapatılması.
Turkish 18.1 KB
2025-08-21 13:57
Regulatory News Service
Kupon ödemesi
Turkish 27.2 KB
2025-08-20 15:50
Capital/Financing Update
TRSDEVA82629 ISIN kodlu tahvilin dördüncü kupon faiz oranı hakkında
English 27.3 KB
2025-08-15 22:46
Environmental & Social Information
Sürdürülebilirlik raporu
Turkish 15.3 KB
2025-08-15 18:35
Environmental & Social Information
TSRS Uyumlu 2024 Yılı Sürdürülebilirlik Raporu
Turkish 2.5 MB
2025-08-15 18:35
Environmental & Social Information
TSRS Uyumlu 2024 Yılı Sürdürülebilirlik Raporu
Turkish 15.2 KB
2025-08-15 18:33
Environmental & Social Information
Participation Finance Principles Information Form
English 52.6 KB
2025-08-15 18:32
Interim Report
Declaration of Responsibility.
Turkish 29.1 KB
2025-08-15 18:32
Interim Report
Activity Report
English 1.4 MB
2025-08-15 18:32
Management Discussion and Analysis
Activity Report
Turkish 1.6 MB
2025-08-15 18:32
Report Publication Announcement
Activity Report
English 13.2 KB

Automate Your Workflow. Get a real-time feed of all DEVA HOLDİNG A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DEVA HOLDİNG A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DEVA HOLDİNG A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Corline Biomedical AB Logo
Develops heparin-based coatings for medical device biocompatibility and regenerative medicine.
Sweden CLBIO
Cosma Spolka Akcyjna Logo
Produces natural hemp supplements and pharmaceutical raw materials for retail & wholesale markets.
Poland COS
COSMO Pharmaceuticals N.V. Logo
Specialty pharma for gastroenterology/dermatology, offering colon treatments & manufacturing services.
Netherlands COPN
Crossject Logo
Develops needle-free auto-injectors for rapid drug delivery in medical emergencies.
France ALCJ
CTC BIO, INC. Logo
Develops pharmaceuticals and feed additives for human and animal health using fermentation tech.
South Korea 060590
Cuorips Inc. Logo
Develops iPS cell therapies, like a cardiomyocyte sheet for severe heart failure.
Japan 4894
curacle co., ltd. Logo
Developing drugs for intractable diseases like diabetes caused by vascular damage and aging.
South Korea 365270
Curevac Logo
Pioneering mRNA technology to create vaccines and therapies for infectious diseases, cancer, and more.
Germany CVAC
Curocell Inc. Logo
Biotech developing enhanced CAR-T therapies for cancer using its OVIS™ platform.
South Korea 372320
Cyfuse Biomedical K.K. Logo Japan 4892

Talk to a Data Expert

Have a question? We'll get back to you promptly.